MPM BioImpact’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
819,924
| – | – | 0.2% | 42 |
|
|
2025
Q1 | $808K | Sell |
819,924
-411,230
| -33% | -$405K | 0.14% | 42 |
|
|
2024
Q4 | $1.61M | Sell |
1,231,154
-408,695
| -25% | -$535K | 0.23% | 47 |
|
|
2024
Q3 | $5.64M | Hold |
1,639,849
| – | – | 0.85% | 31 |
|
|
2024
Q2 | $5.41M | Hold |
1,639,849
| – | – | 0.84% | 37 |
|
|
2024
Q1 | $7.72M | Hold |
1,639,849
| – | – | 1.24% | 33 |
|
|
2023
Q4 | $12M | Hold |
1,639,849
| – | – | 2.8% | 12 |
|
|
2023
Q3 | $19.8M | Hold |
1,639,849
| – | – | 5.29% | 4 |
|
|
2023
Q2 | $17.3M | Hold |
1,639,849
| – | – | 3.49% | 9 |
|
|
2023
Q1 | $16.1M | Hold |
1,639,849
| – | – | 4.19% | 10 |
|
|
2022
Q4 | $24.1M | Hold |
1,639,849
| – | – | 6.26% | 4 |
|
|
2022
Q3 | $19.9M | Hold |
1,639,849
| – | – | 4.71% | 6 |
|
|
2022
Q2 | $22.9M | Hold |
1,639,849
| – | – | 6.37% | 3 |
|
|
2022
Q1 | $23.4M | Hold |
1,639,849
| – | – | 6.27% | 4 |
|
|
2021
Q4 | $34.6M | Hold |
1,639,849
| – | – | 6.3% | 3 |
|
|
2021
Q3 | $43M | Sell |
1,639,849
-36,238
| -2% | -$951K | 6.67% | 3 |
|
|
2021
Q2 | $52.3M | Sell |
1,676,087
-393,662
| -19% | -$12.3M | 8.59% | 4 |
|
|
2021
Q1 | $63.5M | Sell |
2,069,749
-318,588
| -13% | -$9.78M | 7.98% | 5 |
|
|
2020
Q4 | $81.9M | Hold |
2,388,337
| – | – | 14.39% | 2 |
|
|
2020
Q3 | $73.5M | Hold |
2,388,337
| – | – | 17.71% | 1 |
|
|
2020
Q2 | $74.1M | Buy |
+2,388,337
| New | +$74.1M | 19.7% | 1 |
|